Evaluatieagenda Reumatologie
-
CHildren with Arthritis: Monotherapy or Polytherapy (CHAMP). A multicentre, single-blinded, randomized treat to target, one-year follow-up clinical trial in patients with recent onset juvenile idiopathic arthritis (JIA)
-
Introduction of a biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis
-
Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support program
-
Personalized dose reduction of biological drugs in Rheumatoid Arthritis patients using dynamic prediction